| [1] |
Ku TK, Crowe DL. Coactivator-mediated estrogen response in human squamous cell carcinoma lines [J]. J Endocrinol,2007,193(1):147-155.
|
| [2] |
Charlier TD, Cornil CA, Ball GF, et al. Diversity of mechanisms involved in aromatase regulation and estrogen action in the brain [J]. Biochim Biophys Acta,2010,1800(10):1094-105.
|
| [3] |
Budefeld T, Tobet SA, Majdic G. Steroidogenic factor 1 and the central nervous system [J]. J Neuroendocrinol, 2012,24(1):225-235.
|
| [4] |
Zhang D, Guo Q,Bian C,et al. Alterations of steroid receptor coactivator-1 (SRC-1) immunoreactivities in specific brain regions of young and middle-aged female Sprague-Dawley rats [J]. Brain Res,2011,1382:88-97.
|
| [5] |
Onate SA,Tsai SY,Tsai MJ,et al. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily[J]. Science,1995,270(5240):1354-1357.
|
| [6] |
Anzick SL, Kononen J, Walker RL, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer[J]. Science,1997,277(5328):965-968.
|
| [7] |
Kalkhoven E, Valentine JE, Heery DM, et al. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor [J]. EMBO J,1998,17:232-243.
|
| [8] |
Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family [J]. Mol Endocrinol,2003,17(9):1681-1692.
|
| [9] |
Xu J, Wu RC, O'Malley BW.Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family[J]. Nat Rev Cancer,2009,9(9):615-630.
|
| [10] |
Li S, Shang Y. Regulation of SRC family coactivators by post-translational modifications [J]. Cell Signal,2007,19(6):1101-1012.
|
| [11] |
Fleming FJ, Hill AD, McDermott EW, et al. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer [J]. J Clin Endocrinol Metab,2004,89(1):375-383.
|
| [12] |
Fleming FJ, Myers E, Kelly G, et al. Expression of SRC-1, AIB1, and PEA3 in HER-2 mediated endocrine resistant breast cancer; a predictive role for SRC-1 [J]. J Clin Pathol,2004,57(10):1069-1074.
|
| [13] |
Myers E, Fleming FJ, Crotty TB, et al. Inverse relationship between ER-beta and SRC-1 predicts outcome in endocrineresistant breast cancer [J]. Br J Cancer,2004,91(9):1687-1693.
|
| [14] |
Hudelist G, Czerwenka K, Kubista E, et al. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator [J]. Breast Cancer Res Treat,2003,78(2):193-204.
|
| [15] |
List HJ, Reiter R, Singh B, et al. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue [J].Breast Cancer Res Treat,2001,68(1):21-28.
|
| [16] |
Qin L, Liao L, Redmond A, et al. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression [J]. Mol Cell Biol,2008,28(19):5937-5950.
|
| [17] |
Wang S, Yuan Y, Liao L, et al. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation [J]. Proc Natl Acad Sci USA,2009,106(1):151-156.
|
| [18] |
Weldon CB, Elliott S, Zhu Y, et al. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators[J]. Surgery,2004,136(2):346-354.
|
| [19] |
Han JS, Crowe DL. Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands [J]. BMC Cancer,2010,10:629-643.
|
| [20] |
Wei X,Xu H,Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor α [J]. Mol Cell,2006,21(2):295-305.
|
| [21] |
Karmakar S, Foster EA, Smith CL.Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity[J]. Endocrinology,2009,150(4):1588-1596.
|
| [22] |
Qin L, Liu ZL, Chen HW, et al. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis [J]. Cancer Res,2009,69(9):3819-3827.
|
| [23] |
Qin L, Chen X, Wu YL, et al. Steroid receptor coactivator-1 upregulates integrin α 5 expression to promote breast cancer cell adhesion and migration [J]. Cancer Res,2011,71(5):1742-1751.
|
| [24] |
李东梅,冯玉梅. 黏附分子介导的信号转导与乳腺癌转移[J/CD]. 中华乳腺病杂志:电子版, 2009, 3(5):549-558.
|
| [25] |
Kishimoto H, Wang Z, Bhat-Nakshatri P, et al. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1 α/CXCL12 [J]. Carcinogenesis,2005,26(10):1706-1715.
|
| [26] |
Redmond AM, Bane FT, Stafford AT, et al. Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence [J]. Clin Cancer Res,2009,15(6):2098-2106.
|
| [27] |
McIlroy M, McCartan D, Early S, et al. Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer corrected [J]. Cancer Res, 2010, 70(4):1585-1594.
|
| [28] |
Hurtado A, Holmes KA, Geistlinger TR, et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.[J]. Nature,2008,456(7222):663-666.
|
| [29] |
Chen B, Wang Y, Kane SE, et al. Improvement of sensitivity to tamoxifen in estrogen receptor-positive and Herceptinresistant breast cancer cells [J]. J Mol Endocrinol,2008,41(5):67-77.
|
| [30] |
Flågeng MH,Moi LL, Dixon JM, et al. Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors [J]. Br J Cancer,2009,101(8):1253-1260.
|